“Thirty years ago, there was nothing we could do for these patients,” said Dr Roy Herbst, the deputy director of Yale CancerCenter and lead author of the study. “Now we have this potent drug.”
Its a shame Immutep doesn’t have someone of Herbst caliber talking up Efti is such glowing terms- “Thrilling”, “New SoC”
It works on the EGFR gene found in 25% of NSCLC cases globally and 40% in Asia.
Maybe you should read the article before you post BS. Lol.
Media, page-421
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.3¢ |
Change
-0.003(0.88%) |
Mkt cap ! $406.7M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $1.273M | 4.536M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25423 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 55960 | 2 |
View Market Depth
| Last trade - 15.59pm 04/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |